During the past decade, York Dermatology Clinic and Research Centre conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 14 clinical trials were completed, i.e. on average, 60.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 14 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "York Dermatology Clinic and Research Centre" #1 sponsor was "Pfizer" with 6 trials, followed by "Asana BioSciences" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Aristea Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "York Dermatology Clinic and Research Centre" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "York Dermatology Clinic and Research Centre" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "York Dermatology Clinic and Research Centre" are "Atopic Dermatitis" (7 trials), "Dermatitis, Atopic" (5 trials), "Alopecia Areata" (4 trials), "Hidradenitis Suppurativa" (4 trials) and "Psoriasis" (3 trials). Many other conditions were trialed in "York Dermatology Clinic and Research Centre" in a lesser frequency.

Most popular intervention types in "York Dermatology Clinic and Research Centre" are "Drug" (21 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "ASN002" (2 trials), "PF-04965842 100 mg" (2 trials), "PF-04965842 200 mg" (2 trials) and "PF-06651600" (2 trials). Other intervention names were less common.

The vast majority of trials in "York Dermatology Clinic and Research Centre" are 23 trials for "All" genders.

Currently, there are NaN active trials in "York Dermatology Clinic and Research Centre". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in York Dermatology Clinic and Research Centre, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in York Dermatology Clinic and Research Centre, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".